Status migrainosus in children and adolescents: A systematic literature review of demographic and clinical characteristics, precipitating factors, prognosis, treatments, and response
Open Access
- 26 July 2026
- journal article
- review article
- Published by SAGE Publications in Cephalalgia Reports
- Vol. 9
Abstract
Background: Status migrainosus (SM) is a prolonged migraine attack lasting over 72 hours. Pediatric-specific data on SM remain sparse. Methods: Searches were conducted in six medical databases to July 2025. Eligible studies included clinical trials, cohorts, and case series (≥5 patients) reporting SM. Independent reviewers conducted screening, extraction, and quality appraisal. Results: Of 658 studies, 17 ( n = 7161;1857 pediatric SM cases) were included—predominantly single-center, retrospective studies, without randomized controlled trials. Most SM cohorts showed a female, adolescent (13–16 years) preponderance. SM's management strategies were heterogeneous; with peripheral nerve (PNB) and sphenopalatine ganglion (SPG) blocking procedures (3 studies, 690 patients) and anti-seizure medications (2 studies using valproate, 146 patients) being commonly reported. PNB and SPG blocking procedures were associated with short-term improvement and safety. In one comparative study of 94 patients, lidocaine infusions showed a trend toward faster pain relief and fewer adverse effects than IV valproate. One study of 177 patients directly compared IV dihydroergotamine to PNB, identifying a longer hospital duration of stay among dihydroergotamine recipients but a better response rate. Factors associated with poor response included older age, anxiety, medication overuse, and baseline severity. Among others, self-reported psychological stress was an SM trigger in two studies. Interpretation: Available evidence on SM in pediatric populations remains limited by non-randomized evidence, prone to inherent bias. Consequently, multicenter, comparative, randomized trials are warranted to establish pediatric-specific protocols. Observational evidence suggests that PNB/SPG blocking procedures may offer promise to those with failure of medical management strategies. Trial Registration: This PRISMA-compliant review was prospectively registered on PROSPERO (CRD420251088970).Keywords
This publication has 29 references indexed in Scilit:
- Utility of greater occipital nerve anesthetic blockade in the treatment of status migrainosus in the pediatric emergency departmentEuropean Journal of Paediatric Neurology, 2025
- Peripheral Nerve Blocks: A Tool for Inpatient Pediatric Status MigrainosusPediatric Neurology, 2022
- Safety and Efficacy of IV Lidocaine in the Treatment of Children and Adolescents With Status Migraine*Pediatric Critical Care Medicine, 2018
- Continuous Intravenous Valproate as Abortive Therapy for Pediatric Status MigrainosusThe Neurologist, 2018
- Outcome and Cost of Inpatient Hospitalization for Intravenous Dihydroergotamine Treatment of Refractory Pediatric HeadachePediatric Neurology, 2016
- The Use of a Pediatric Migraine Practice Guideline in an Emergency Department SettingPediatric Emergency Care, 2016
- Intravenous Magnesium As Acute Treatment for Headaches: A Pediatric Case SeriesThe Journal of Emergency Medicine, 2014
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Modulation of visual cortex excitability in migraine with aura: Effects of valproate therapyNeuroscience Letters, 2009
- Status migrainosus in children and adolescentsSeminars in Pediatric Neurology, 2001